Bank of New York Mellon Corp purchased a new stake in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 186,945 shares of the financial services provider's stock, valued at approximately $4,631,000. Bank of New York Mellon Corp owned approximately 0.43% of Trupanion as of its most recent SEC filing.
Several other hedge funds also recently bought and sold shares of the company. State of Wyoming bought a new position in Trupanion during the second quarter valued at approximately $452,000. Kelleher Financial Advisors bought a new stake in Trupanion in the 2nd quarter valued at $42,000. GSA Capital Partners LLP acquired a new stake in shares of Trupanion during the 2nd quarter worth approximately $1,394,000. Kopion Asset Management LLC boosted its stake in Trupanion by 30.9% during the second quarter. Kopion Asset Management LLC now owns 522,999 shares of the financial services provider's stock worth $12,955,000 after buying an additional 123,308 shares in the last quarter. Finally, Parallel Advisors LLC boosted its holdings in Trupanion by 1,831.9% during the first quarter. Parallel Advisors LLC now owns 1,816 shares of the financial services provider's stock valued at $47,000 after purchasing an additional 1,722 shares in the last quarter.
Trupanion Trading Down 3.4%
Shares of Trupanion stock opened at $27.80 on Friday. The stock has a market cap of $1.22 billion, a P/E ratio of 52.45, a P/E/G ratio of 1.88 and a beta of 1.45. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.24. Trupanion, Inc. has a 12-month low of $21.16 and a 12-month high of $46.98. The business's 50 day moving average is $27.44 and its 200-day moving average is $25.88.
Trupanion (NASDAQ:TRUP - Get Free Report) last released its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.05. The business had revenue of $392.93 million during the quarter, compared to analysts' expectations of $389.72 million. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The firm's revenue was up 11.1% on a year-over-year basis. During the same period last year, the business earned $0.22 earnings per share. Equities research analysts predict that Trupanion, Inc. will post 0.63 earnings per share for the current fiscal year.
Insider Activity
In other news, COO John Gallagher sold 3,604 shares of Trupanion stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $29.70, for a total transaction of $107,038.80. Following the completion of the transaction, the chief operating officer directly owned 33,742 shares in the company, valued at approximately $1,002,137.40. The trade was a 9.65% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Margaret Tooth sold 978 shares of Trupanion stock in a transaction on Tuesday, August 11th. The stock was sold at an average price of $29.05, for a total transaction of $28,410.90. Following the transaction, the chief executive officer directly owned 175,401 shares of the company's stock, valued at approximately $5,095,399.05. This trade represents a 0.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 12,046 shares of company stock valued at $356,210 over the last three months. Insiders own 5.58% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on TRUP shares. Piper Sandler lowered shares of Trupanion from an "overweight" rating to a "neutral" rating and lowered their target price for the stock from $45.00 to $32.00 in a report on Wednesday, August 26th. Stifel Nicolaus increased their price objective on Trupanion from $28.00 to $29.00 and gave the company a "hold" rating in a research report on Thursday, August 20th. Zacks Research cut Trupanion from a "strong-buy" rating to a "hold" rating in a research note on Monday, August 24th. Weiss Ratings raised shares of Trupanion from a "hold (c-)" rating to a "hold (c)" rating in a report on Wednesday, August 26th. Finally, Atlantic Securities set a $42.00 price target on shares of Trupanion in a research report on Wednesday, July 15th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, Trupanion presently has a consensus rating of "Hold" and an average target price of $39.20.
View Our Latest Report on TRUP
About Trupanion
(
Free Report)
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company's core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Read More
Want to see what other hedge funds are holding TRUP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Trupanion, Inc. (NASDAQ:TRUP - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Trupanion, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.
While Trupanion currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.